药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin detemir
Detomidine
The risk or severity of adverse effects can be increased when Detomidine is combined with Levomilnacipran.
Insulin detemir
Tricaine
The risk or severity of adverse effects can be increased when Tricaine is combined with Levomilnacipran.
Insulin detemir
Tiletamine
The risk or severity of adverse effects can be increased when Tiletamine is combined with Levomilnacipran.
Insulin detemir
Romifidine
The risk or severity of adverse effects can be increased when Romifidine is combined with Levomilnacipran.
Insulin detemir
Propiopromazine
The risk or severity of adverse effects can be increased when Propiopromazine is combined with Levomilnacipran.
Insulin detemir
Xylazine
The risk or severity of adverse effects can be increased when Xylazine is combined with Levomilnacipran.
Insulin detemir
Medetomidine
The risk or severity of adverse effects can be increased when Medetomidine is combined with Levomilnacipran.
Insulin detemir
Doramectin
The risk or severity of adverse effects can be increased when Doramectin is combined with Levomilnacipran.
Insulin detemir
Alfaxalone
The risk or severity of adverse effects can be increased when Alfaxalone is combined with Levomilnacipran.
Insulin detemir
Pyrantel
The risk or severity of adverse effects can be increased when Pyrantel is combined with Levomilnacipran.
Insulin detemir
Ramosetron
The risk or severity of adverse effects can be increased when Ramosetron is combined with Levomilnacipran.
Insulin detemir
Iproclozide
The risk or severity of adverse effects can be increased when Iproclozide is combined with Levomilnacipran.
Insulin detemir
Blonanserin
The risk or severity of adverse effects can be increased when Blonanserin is combined with Levomilnacipran.
Insulin detemir
Etoperidone
The risk or severity of adverse effects can be increased when Etoperidone is combined with Levomilnacipran.
Insulin detemir
Talopram
The risk or severity of adverse effects can be increased when Talopram is combined with Levomilnacipran.
Insulin detemir
Lortalamine
The risk or severity of adverse effects can be increased when Lortalamine is combined with Levomilnacipran.
Insulin detemir
Nisoxetine
The risk or severity of adverse effects can be increased when Nisoxetine is combined with Levomilnacipran.
Insulin detemir
Edivoxetine
The risk or severity of adverse effects can be increased when Edivoxetine is combined with Levomilnacipran.
Insulin detemir
Brexpiprazole
The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Levomilnacipran.
Insulin detemir
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Levomilnacipran.